Jen Chew is a senior principal scientist on the Platform team focused on developing new technologies that utilize genomics to enable more efficient identification of cell-type specific therapies. Prior to joining Cartography, she was a senior scientist in the molecular biology department at 10X Genomics, where she investigated new methods for studying spatial gene and protein expression. In her spare time, she enjoys cheering for LA-based sports teams (go Dodgers!), skiing in Tahoe, and playing with her two cats, Nacho and Charlie.
Recent Posts
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
- Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
Recent Comments
No comments to show.